NRC
$17.73
National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
Recent News
What Makes National Research Corporation (NRC) a Good Investment Choice?
Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Portfolio’s cumulative net return increased by 1%, but the cumulative portfolio for the year remained flat. Since its inception in November 2015, the portfolio has delivered a cumulative return […]
NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%
NRC Health's Q4 EPS and revenues decline year amid prior client attrition, though recurring contract value grew 8%, pointing to recovery prospects in 2026.
A Look At The Fair Value Of National Research Corporation (NASDAQ:NRC)
Key Insights National Research's estimated fair value is US$15.13 based on 2 Stage Free Cash Flow to Equity Current...
National Research Q4 Earnings Call Highlights
National Research (NASDAQ:NRC) executives pointed to improving sales momentum and recurring contract value growth during the company’s fourth-quarter earnings call, while acknowledging year-over-year revenue pressure tied to elevated attrition experienced in 2024. Fourth-quarter results For the fou
National Research Says Pairing NPS With HCAHPS Can Boost Patient Experience—and Reimbursement
National Research (NASDAQ:NRC) leaders Sarah Fryda and Jason Messerli told webcast attendees that hospitals can use Net Promoter Score (NPS) and other real-time patient feedback tools to strengthen performance on the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, a